Profile | GDS4284 / 210634_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 78.1068 | 32 |
GSM687648 | Patient 402 control | 20.842 | 13 |
GSM687653 | Patient 403 control | 81.8391 | 32 |
GSM687658 | Patient 404 control | 164.601 | 44 |
GSM687663 | Patient 411 control | 264.404 | 53 |
GSM687668 | Patient 422 control | 75.2833 | 29 |
GSM687673 | Patient 424 control | 264.137 | 52 |
GSM687678 | Patient 425 control | 207.04 | 48 |
GSM687683 | Patient 427 control | 172.618 | 43 |
GSM687688 | Patient 428 control | 6.42004 | 3 |
GSM687695 | Patient 441 control | 33.2609 | 10 |
GSM687699 | Patient 443 control | 108.77 | 32 |
GSM687704 | Patient 444 control | 199.299 | 48 |
GSM687707 | Patient 448 control | 457.714 | 62 |
GSM687712 | Patient 449 control | 256.141 | 52 |
GSM687719 | Patient 450 control | 231.488 | 48 |
GSM687724 | Patient 451 control | 252.232 | 51 |
GSM687728 | Patient 452 control | 28.9714 | 15 |
GSM687646 | Patient 401 treated 24h | 201.43 | 48 |
GSM687649 | Patient 402 treated 24h | 121.426 | 40 |
GSM687665 | Patient 411 treated 24h | 94.7572 | 31 |
GSM687651 | Patient 402 treated 4 weeks | 278.662 | 53 |
GSM687667 | Patient 411 treated 4 weeks | 205.235 | 48 |
GSM687670 | Patient 422 treated 24h | 191.258 | 46 |
GSM687671 | Patient 422 treated 4 weeks | 276.436 | 54 |
GSM687654 | Patient 403 treated 24h | 117.798 | 40 |
GSM687675 | Patient 424 treated 24h | 176.623 | 44 |
GSM687685 | Patient 427 treated 24h | 13.5636 | 8 |
GSM687656 | Patient 403 treated 4 weeks | 113.238 | 40 |
GSM687677 | Patient 424 treated 4 weeks | 51.0089 | 23 |
GSM687687 | Patient 427 treated 4 weeks | 180.272 | 48 |
GSM687692 | Patient 428 treated 4h | 112.024 | 36 |
GSM687716 | Patient 449 treated 4h | 35.8627 | 18 |
GSM687722 | Patient 450 treated 4h | 61.4536 | 23 |
GSM687680 | Patient 425 treated 24h | 22.8479 | 13 |
GSM687690 | Patient 428 treated 24h | 14.9068 | 9 |
GSM687700 | Patient 443 treated 24h | 196.422 | 40 |
GSM687705 | Patient 444 treated 24h | 67.8451 | 29 |
GSM687714 | Patient 449 treated 24h | 148.512 | 44 |
GSM687721 | Patient 450 treated 24h | 229.326 | 47 |
GSM687682 | Patient 425 treated 4 weeks | 147.697 | 43 |
GSM687694 | Patient 428 treated 4 weeks | 39.2467 | 21 |
GSM687702 | Patient 443 treated 4 weeks | 194.715 | 45 |
GSM687718 | Patient 449 treated 4 weeks | 118.915 | 37 |
GSM687723 | Patient 450 treated 4 weeks | 174.328 | 44 |
GSM687661 | Patient 404 treated 4h | 207.303 | 48 |
GSM687710 | Patient 448 treated 4h | 225.989 | 51 |
GSM687726 | Patient 451 treated 4h | 306.136 | 54 |
GSM687730 | Patient 452 treated 4h | 320.816 | 43 |
GSM687660 | Patient 404 treated 24h | 128.699 | 34 |
GSM687697 | Patient 441 treated 24h | 15.0768 | 5 |
GSM687709 | Patient 448 treated 24h | 295.655 | 55 |
GSM687725 | Patient 451 treated 24h | 311.172 | 54 |
GSM687729 | Patient 452 treated 24h | 222.879 | 44 |
GSM687727 | Patient 451 treated 4 weeks | 306.371 | 54 |
GSM687731 | Patient 452 treated 4 weeks | 224.07 | 48 |